Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 2
2007 2
2014 1
2016 3
2017 2
2018 3
2019 1
2020 3
2021 4
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Engineering builds multipotency for iPSC-NKs.
Rahnama R, Bonifant CL. Rahnama R, et al. Among authors: bonifant cl. Blood. 2022 Dec 8;140(23):2414-2416. doi: 10.1182/blood.2022017794. Blood. 2022. PMID: 36480219 Free article. No abstract available.
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
Christodoulou I, Ho WJ, Marple A, Ravich JW, Tam A, Rahnama R, Fearnow A, Rietberg C, Yanik S, Solomou EE, Varadhan R, Koldobskiy MA, Bonifant CL. Christodoulou I, et al. Among authors: bonifant cl. J Immunother Cancer. 2021 Dec;9(12):e003894. doi: 10.1136/jitc-2021-003894. J Immunother Cancer. 2021. PMID: 34896980 Free PMC article.
Improving CAR T-cells: The next generation.
Marple AH, Bonifant CL, Shah NN. Marple AH, et al. Among authors: bonifant cl. Semin Hematol. 2020 Jul;57(3):115-121. doi: 10.1053/j.seminhematol.2020.07.002. Epub 2020 Jul 23. Semin Hematol. 2020. PMID: 33256900 Review.
Targeting glycans for CAR therapy: The advent of sweet CARs.
Raglow Z, McKenna MK, Bonifant CL, Wang W, Pasca di Magliano M, Stadlmann J, Penninger JM, Cummings RD, Brenner MK, Markovitz DM. Raglow Z, et al. Among authors: bonifant cl. Mol Ther. 2022 Sep 7;30(9):2881-2890. doi: 10.1016/j.ymthe.2022.07.006. Epub 2022 Jul 12. Mol Ther. 2022. PMID: 35821636 Free PMC article. Review.
Toxicity and management in CAR T-cell therapy.
Bonifant CL, Jackson HJ, Brentjens RJ, Curran KJ. Bonifant CL, et al. Mol Ther Oncolytics. 2016 Apr 20;3:16011. doi: 10.1038/mto.2016.11. eCollection 2016. Mol Ther Oncolytics. 2016. PMID: 27626062 Free PMC article. Review.
Mediport use as an acceptable standard for CAR T cell infusion.
Eylon M, Prabhu S, John S, King MJM, Bhatt D, Curran KJ, Erickson C, Karras NA, Phillips CL, Satwani P, Hermiston M, Southworth E, Baumeister SHC, Talano JA, MacMillan ML, Rossoff J, Bonifant CL, Myers GD, Rouce RH, Toner K, Driscoll TA, Katsanis E, Salzberg DB, Schiff D, De Oliveira SN, Capitini CM, Pacenta HL, Pfeiffer T, Shah NC, Huynh V, Skiles JL, Fraint E, McNerney KO, Quigg TC, Krueger J, Ligon JA, Fabrizio VA, Baggott C, Laetsch TW, Schultz LM. Eylon M, et al. Among authors: bonifant cl. Front Immunol. 2023 Oct 27;14:1239132. doi: 10.3389/fimmu.2023.1239132. eCollection 2023. Front Immunol. 2023. PMID: 37965315 Free PMC article.
32 results